Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Research ArticleArticle

Heart Disease Is Still a Primary Emphasis

Carl J. Lavie
Ochsner Journal December 2009, 9 (4) 173-174;
Carl J. Lavie
Medical Director, Cardiac Rehabilitation and Prevention, and Director, Exercise Laboratories, Ochsner Clinic Foundation, New Orleans, LA, Guest Editor, The Ochsner Journal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States (US) and all of Westernized civilization. Although welcome declines in CVD mortality have been occurring for several decades, recent statistics suggest that the epidemic of overweightness and obesity is placing a serious threat to the development of CVD, and if current trends continue, it has been predicted that we may soon notice a reversal in the decline in CVD morbidity and mortality.1 Clearly, the prevention, assessment, and treatment of CVD remain serious concerns.

In recent years, great emphasis has been placed on the role of C-reactive protein (CRP) for predicting CVD risk and clinical prognosis. In fact, data from Ochsner Clinic have emphasized the importance of CRP in preventive cardiology.2–4 In this issue of the Journal, Drs. Milani and Lavie report original data from Ochsner's Cardiac Rehabilitation and Exercise Training Program in 635 consecutive patients, demonstrating the role of CRP in predicting blood pressure responsiveness to a standard lifestyle intervention program.

Several studies from Ochsner Cardiology have focused on the prognostic impact of left ventricular (LV) geometry on clinical prognosis,5–9 including studies in The Ochsner Journal.10 Dr. Edward Frohlich, perhaps the foremost authority in the world on LV geometry, particularly the importance of LV hypertrophy or LVH in hypertension, provides an excellent, state-of-the-art review of this topic. In addition to LV geometry, recent work has focused on the importance of the left atrium (LA) in CVD and prediction of prognosis. Dr. Dharm Patel has award-winning research from Ochsner Clinic resulting in more than 15 major oral and poster presentations on LV geometry and the LA at the national meetings of the American Heart Association and the American College of Cardiology, as well as other national and international meetings, during the past 2 years. He and his mentors review the recent evidence exploring the clinical implications of LA enlargement.

It has been well known that salt consumption plays a role in the development of hypertension and worsening in volume overload in patients with heart failure (HF). However, sodium intake plays a role in CVD well beyond simply increasing arterial pressure, which is reviewed in detail by Drs. Susic, Frohlich, and colleagues. As mentioned previously, CRP has been a major topic during the past decade and has become even “hotter” with publication of the recent JUPITER trial.11 The implications of the JUPITER trial, particularly regarding the routine assessment of CRP, are reviewed by Dr. Verma and his mentors.

For more than two decades, Ochsner Cardiology staff have been leaders in the area of percutaneous intervention, not just in the coronary circulation but also the peripheral circulation (cerebral vessels, renal vessels, and lower extremity and mesenteric circulation). In fact, Dr. Chris White, the head of the Department of Cardiovascular Diseases at Ochsner, has been editor of the Catheterization and Cardiovascular Intervention journal for many years; additionally, the head of the Ochsner Catheterization Laboratory, Dr. Steve Ramee, along with Drs. Tyrone Collins, Steve Jenkins, and colleagues, have been associate/section editors of this prestigious interventional journal. In this issue of the Journal, Drs. Jaffrey and Grant of the Ochsner Interventional team review data regarding multisystem percutaneous revascularization. Many patients, however, often with very severe diffuse vascular disease, remain resistant to standard medical therapies, as well as aggressive interventions, and Drs. Verma and Grise review treatment options for these patients.

During recent years, the diagnosis of HF has been increasing and has been the leading cause of hospitalizations and overall morbidity in the US. The Ochsner HF and Transplantation Division has been headed by Dr. Hector Ventura, who is world renowned in the fields of hypertension, HF, and cardiac transplantation. In this issue, Drs. Gaddam, Ventura, and colleagues review strategies for patients with advanced HF. Along with HF, pulmonary hypertension (PH) is being emphasized by our advanced HF program, and Drs. Thompson, Hamang Patel, and colleagues review the importance of PH in modern practice.

Electrophysiologic techniques have been advancing at a rapid pace. A major issue in electrophysiology has been atrial fibrillation (AF), which along with obesity is increasing in epidemic proportions and may be lessened with omega-3 fatty acids.12,13 In this issue, Drs. Saad, Morin, and Khatib discuss current concepts in AF. Dr. Owen and mentors discuss the role of advanced pacing with cardiac resynchronization therapy, which has been demonstrated to improve quality of life, reduce hospitalizations, and probably increase survival in some patients with advanced HF.

Like electrophysiologic techniques, advanced cardiac imaging technologies have also been proliferating. Although the leading imaging modalities for patients with CVD have typically been echocardiography and nuclear imaging, cardiac CT scanning (reviewed by Drs. Dinshaw, Delaney, and Reilly) and magnetic resonance imaging (reviewed by Drs. Shah, Chryssos, and Parker) are aiding in the noninvasive evaluation of many patients with complex CVD.

Finally, sudden cardiac death (SCD) remains one of the leading causes of death, and this catastrophe may also be partly prevented with omega-3 fatty acids.12–14 Although many patients with SCD expire before reaching the hospital, the prognosis for patients with SCD who initially “survive” remains dismal. Drs. Alkadri and McMullan discuss a promising new modality of induced hypothermia as a neuroprotectant therapy to hopefully improve the meaningful survival in patients resuscitated from SCD.

The prevention, assessment, and treatment of patients with CVD remain one of the leading medical issues in the US. I greatly appreciate the efforts of my colleagues who have contributed these outstanding articles to this cardiovascular symposium.

  • Academic Division of Ochsner Clinic Foundation

REFERENCES

  1. ↵
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Ventura H. O.
    (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925–1932, pmid:19460605.
    OpenUrlFREE Full Text
  2. ↵
    1. Milani R. V.,
    2. Lavie C. J.,
    3. Mehra M. R.
    (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 43:1056–1061, pmid:15028366.
    OpenUrlFREE Full Text
    1. Milani R. V.,
    2. Lavie C. J.
    (2003) Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 92:50–54, pmid:12842245.
    OpenUrlPubMed
  3. ↵
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Verma A.,
    4. O'Keefe J. H.
    (2009) C-reactive protein and cardiovascular disease: is it ready for primetime? Am J Med Sci 338:486–492, pmid:20010156.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Milani R. V.,
    2. Lavie C. J.,
    3. Mehra M. R.,
    4. Ventura H. O.,
    5. Kurtz J. D.,
    6. Messerli F. H.
    (2006) Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol 97:959–963, pmid:16563894.
    OpenUrlCrossRefPubMed
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Ventura H. O.,
    4. Messerli F. H.
    (2006) Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol 98:1396–1399, pmid:17134637.
    OpenUrlCrossRefPubMed
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Ventura H. O.,
    4. Cardenas G. A.,
    5. Mehra M. R.,
    6. Messerli F. H.
    (2007) Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 100:1460–1464, pmid:17950808.
    OpenUrlCrossRefPubMed
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Patel D.,
    4. Artham S. M.,
    5. Ventura H. O.
    (2009) Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 121:119–125, pmid:19491549.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Artham S. M.,
    2. Lavie C. J.,
    3. Milani R. V.,
    4. Patel D. A.,
    5. Verma A.,
    6. Ventura H. O.
    (2009) Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 52:153–167, pmid:19732607.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Shah S. B.,
    4. et al.
    (2008) Impact of left ventricular geometry on prognosis—a review of Ochsner studies. Ochsner J 8:11–17.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Ridker P. M.,
    2. Danielson F.,
    3. Fonesca F. A.,
    4. et al.
    (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl Med 359:2195–2207.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Lavie C. J.,
    2. Milani R. V.,
    3. Mehra M. R.,
    4. Ventura H. O.
    (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54:585–594, pmid:19660687.
    OpenUrlFREE Full Text
  9. ↵
    1. Artham S. M.,
    2. Lavie C. J.,
    3. Milani R. V.,
    4. Anand R. G.,
    5. O'Keefe J. H.,
    6. Ventura H. O.
    (2008) Fish oil in primary and secondary cardiovascular prevention. Ochsner J 8:49–60.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Lavie C. J.,
    2. Milani R. V.,
    3. O'Keefe J. H.
    (2008) The Russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J 8:108–113.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 9, Issue 4
Dec 2009
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Heart Disease Is Still a Primary Emphasis
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Heart Disease Is Still a Primary Emphasis
Carl J. Lavie
Ochsner Journal Dec 2009, 9 (4) 173-174;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Heart Disease Is Still a Primary Emphasis
Carl J. Lavie
Ochsner Journal Dec 2009, 9 (4) 173-174;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • From the Editor's Desk: A Focus on Organ Transplantation
  • Clinical Images: Interventional Management of Pediatric Rex Shunt Stenosis
  • Letters to the EditorBeware of Right Renal Vein Valves in Transplanted Kidneys: Renal Vein Valvuloplasty in a Donor KidneySeizure Caused by Tumor Necrosis Factor-Alpha Inhibitor-Induced Central Nervous System DemyelinationPositron Emission Tomography-Positive Pleural-Based Nodule Following Talc Pleurodesis
Show more Article

Similar Articles

Current Post at the Blog

Elsevier Editors Resign Over Open-Access Fees

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2023 Ochsner Clinic Foundation

Powered by HighWire